Cafepharma Today

January 3 2025 - Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Lilly asks to join GLP-1 compounding lawsuit
Use of diabetes and anti-obesity drugs surges nationwide
How pharma was instrumental in President Jimmy Carter’s global health efforts
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Early Glance: Biotechnology companies
Yahoo/AP
Monday, August 25, 2008 - 10:56am
tags:
Amgen is poised for higher opening following approval of rare blood-clotting disorder drug
Yahoo/AP
Monday, August 25, 2008 - 9:16am
tags:
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Yahoo
Monday, August 25, 2008 - 7:48am
tags:
Glaxo's HIV-Drug Ads Draw Critics
WSJ Online
Monday, August 25, 2008 - 6:06am
tags:
Ranbaxy Falls After Dow Says India to Review Purchase
Bloomberg
Monday, August 25, 2008 - 5:56am
tags:
Nicox says Pfizer drops glaucoma drug study in Asia
Yahoo/Reuters
Monday, August 25, 2008 - 5:55am
tags:
Eisai Wins U.S. Approval to Sell Nausea Drug Aloxi in Capsules
Bloomberg
Sunday, August 24, 2008 - 10:16pm
tags:
The Long Case for Pfizer
Seeking Alpha
Sunday, August 24, 2008 - 4:00pm
tags:
Dr Reddy's plans to brand US speciality drugs
Business Standard, India
Sunday, August 24, 2008 - 10:32am
tags:
Antibody Engineering Cuts the Collateral Damage of Cancer Drugs
Wired News
Sunday, August 24, 2008 - 10:30am
tags:
New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Recipes Blogging: Kebab-e-Koobideh
In the Pipeline
Recipe Blogging: Varieties of Pickles
In the Pipeline
Targeted Cancer Drugs, Succeeding and Failing
In the Pipeline
Drugs Inside Cells - A Bit of Light
In the Pipeline
HPV Infections: Friend and Foe
In the Pipeline
Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes
Drug Channels
Ripping Through The Crystal
In the Pipeline
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)
Drug Channels
Real High Throughput Chemistry Through Mass Spec
In the Pipeline

Latest Jobs

Vascular Consultant - 1719
League City, Texas, United States
FloodGate Medical
Clinical Specialist - $120K-$130K - Cardiovascular Space (Richmond, Charlottesville, Roanoke)
Roanoke, Virginia, United States
The Hoffman Group - Executive Recruiters
Associate Med device sales rep - diabetes
White Plains, New York, United States
DAVID BAGGA COMPANY
Specialty Account Manager - IVIG
Boston, Massachusetts, United States
CSI Pharmacy
Sales Representative, Iron Specialist, Women's Health - San Bernardino, CA
San Bernardino County, California, United States
RxSalesPros
Account Executive- Columbus
Columbus, Ohio, United States
CCS
Sales Representative, Iron Specialist, Women's Health - Sacramento, CA
Sacramento, California, United States
RxSalesPros
Territory Manager/ Pharmaceutical Sales Representative – Women’s Healthcare
Katy, Texas, United States
ImpactBio
Specialty Account Manager - IVIG
Charlotte, North Carolina, United States
CSI Pharmacy
Ophthalmology Pharmaceutical Sales Representative - Austin North Territory
Austin, Texas, United States
EVERSANA
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information